- Home
- MYND vs LVTX Comparison
MYND vs LVTX Comparison
Compare MYND & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- LVTX
- Stock Information
- Founded
- MYND 1998
- LVTX 2016
- Country
- MYND United States
- LVTX Netherlands
- Employees
- MYND N/A
- LVTX N/A
- Industry
- MYND Other Consumer Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- LVTX Health Care
- Exchange
- MYND Nasdaq
- LVTX Nasdaq
- Market Cap
- MYND 42.3M
- LVTX 33.9M
- IPO Year
- MYND 2017
- LVTX 2021
- Fundamental
- Price
- MYND $0.86
- LVTX $1.32
- Analyst Decision
- MYND
- LVTX Hold
- Analyst Count
- MYND 0
- LVTX 3
- Target Price
- MYND N/A
- LVTX $1.75
- AVG Volume (30 Days)
- MYND 12.2K
- LVTX 34.5K
- Earning Date
- MYND 03-26-2025
- LVTX 08-19-2025
- Dividend Yield
- MYND N/A
- LVTX N/A
- EPS Growth
- MYND N/A
- LVTX N/A
- EPS
- MYND N/A
- LVTX N/A
- Revenue
- MYND $267,380,999.00
- LVTX $4,990,000.00
- Revenue This Year
- MYND N/A
- LVTX N/A
- Revenue Next Year
- MYND N/A
- LVTX N/A
- P/E Ratio
- MYND N/A
- LVTX N/A
- Revenue Growth
- MYND N/A
- LVTX N/A
- 52 Week Low
- MYND $0.61
- LVTX $0.85
- 52 Week High
- MYND $3.89
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- MYND 56.43
- LVTX 49.61
- Support Level
- MYND $0.81
- LVTX $1.28
- Resistance Level
- MYND $1.00
- LVTX $1.38
- Average True Range (ATR)
- MYND 0.10
- LVTX 0.05
- MACD
- MYND 0.00
- LVTX -0.00
- Stochastic Oscillator
- MYND 73.68
- LVTX 26.92
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.